Synthesis of novel trans-4-(substituted-benzamido)-3,4-dihydro-2H-benzo[b]-pyran-3-ol derivatives as potential anticonvulsant agents with a distinctive binding profile.
Chan
W N
WN
SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK.
Evans
J M
JM
Hadley
M S
MS
Herdon
H J
HJ
Jerman
J C
JC
Morgan
H K
HK
Stean
T O
TO
Thompson
M
M
Upton
N
N
Vong
A K
AK
D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis* / Q000378:metabolism; D001549:Benzamides / Q000138:chemical synthesis* / Q000378:metabolism; D001578:Benzopyrans / Q000138:chemical synthesis* / Q000378:metabolism; D001665:Binding Sites; D051379:Mice; D011869:Radioligand Assay; D051381:Rats; D013237:Stereoisomerism; D014316:Tritium
D000927:Anticonvulsants; D001549:Benzamides; D001578:Benzopyrans; C102319:SB 204269; D014316:Tritium